James Archie Harrell Jr Avalo Therapeutics, Inc. (AVTX) insider trading activity

AVTX Quotes by TradingView

James Archie Harrell Jr is Chief Commercial Officer of Avalo Therapeutics, Inc.. Currently has a direct ownership of 36,766 shares of AVTX, which is worth approximately $357,733. The most recent transaction as insider was on Dec 10, 2021, when has been sold 1,093 shares (Common Stock) at a price of $1.57 per share, resulting in proceeds of $1,716. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.8K
0% 3M change
0% 12M change
Total Value Held $357,733

James Archie Harrell Jr Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 10 2021
BUY
Open market or private purchase
$1,716 $1.57 p/Share
1,093 Added 2.89%
36,766 Common Stock
Jun 10 2021
BUY
Open market or private purchase
$17,084 $2.28 p/Share
7,493 Added 17.36%
35,673 Common Stock
Dec 10 2020
BUY
Open market or private purchase
$390 $2.28 p/Share
171 Added 0.6%
28,180 Common Stock
JAH

James Archie Harrell Jr

Chief Commercial Officer
Rockville, MD

Track Institutional and Insider Activities on AVTX

Follow Avalo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTX shares.

Notify only if

Insider Trading

Get notified when an Avalo Therapeutics, Inc. insider buys or sells AVTX shares.

Notify only if

News

Receive news related to Avalo Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVTX